Riskpilot← Back to searchSign inGet full accessInterV Nordic AB
ABActiveOrg 5590213947Sportvägen 28Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20151-4 employees
Revenue 2024
SEK 1,8M
+60% vs 2023
EBITDA margin
9.2%
+335% vs 2023
Equity ratio
22.7%
Financial strength
Net profit 2024
SEK 130K
+278% vs 2023
| Revenue | SEK 1,8M | +60% |
| EBITDA | SEK 169K | +335% |
| Net profit | SEK 130K | +278% |
| Total assets | SEK 1M | +124% |
| Equity | SEK 230K | +130% |
| Employees | — | — |
Legal name
InterV Nordic AB
Org number
5590213947
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
23 juli 2015
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Marknadsföring och försäljning av medicintekniska produkter i Norden, som egentillverkare och distributör. Vi kommer att vara distributör åt Ortopediska medcintekniska företag från olika länder. Huvudsakliga inriktningen kommer arr vara sportmedicin. Vi kommer att fokusera på Sverige, Norge och Danmnark. Våra kunder är läkare på ortopediska kliniker, både privata och landsting.
Address
Sportvägen 28
Email
helena@intervnordic.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 821 | 713 | 1 268 | 1 447 | 1 136 | 1 151 | 1 842 |
| Staff expenses | — | — | — | — | — | — | — | — | −657 |
| EBITDA | 10 | −195 | 57 | −51 | 65 | 304 | −207 | −72 | 169 |
| Depreciation & amort. | −2 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −40 |
| EBIT | 8 | −195 | 57 | −51 | 65 | 304 | −207 | −72 | 129 |
| Net financials | — | −1 | 2 | 4 | — | −6 | — | −1 | 1 |
| Profit before tax | 8 | −195 | 59 | −48 | 65 | 223 | −133 | −73 | 130 |
| Tax | −4 | −0 | −0 | −0 | −0 | −46 | −0 | −0 | — |
| Net profit | 4 | −195 | 59 | −48 | 65 | 177 | −133 | −73 | 130 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 517 | 426 | 522 | 425 | 540 | 679 | 707 | 452 | 1 014 |
| Equity | 54 | −141 | 111 | 63 | 128 | 306 | 173 | 100 | 230 |
| Long-term debt | 245 | 317 | 142 | 137 | 132 | 102 | 102 | 102 | 197 |
| Short-term debt | 218 | 250 | 269 | 225 | 279 | 197 | 432 | 251 | 588 |
| Total debt | 463 | 567 | 411 | 362 | 411 | 299 | 534 | 353 | 785 |
EBITDA margin
9.2%
This company
15.8%
Market median
-42% vs market
20162024
Equity ratio
22.7%
This company
38.2%
Market median
-41% vs market
20162024
Return on equity
56.7%
This company
18.4%
Market median
+208% vs market
20162024
Net profit margin
7.1%
This company
8.1%
Market median
-12% vs market
20162024
Asset turnover
1.82×
This company
1.12×
Market median
+62% vs market
20162024
Debt / equity
3.41×
This company
0.62×
Market median
-450% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-07-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HC Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of InterV Nordic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Helena Christina Moström | Chief Executive Officer | 0 companies |
| Robert Gunnar Ström | Chairman | 0 companies |
| Anna Marie Steiding | Board of Directors | 0 companies |
| Oscar Gunnar Umang Ström | Deputy Board Member | 0 companies |